ABBOTT LABORATORIES — Director's Dealing 2014

Feb 4, 2014

Page 1 of 2

SEC FORM 4

SEC Form 4

SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4	SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.See Instruction 1(b).																	OMB APPROVAL OMB Number: 3235-0287 Expires: December 31, 2014 Estimated average burden hours per response: 0.5
1. Name and Address of Reporting Person* Funck Robert E (Last) (First) (Middle) 100 ABBOTT PARK ROAD (Street) ABBOTT PARK IL 60064 (City) (State) (Zip)				2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES [ ABT] 3. Date of Earliest Transaction (Month/Day/Year) 01/31/2014 4. If Amendment, Date of Original Filed (Month/Day/Year)									5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Vice President, Controller
													6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)				2. Transaction Date (Month/Day/Year)			2A. Deemed Execution Date, if any (Month/Day/Year)		3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)				5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)			6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
									Code	V	Amount	(A) or (D)	Price
Common shares without par value				01/31/2014					M		2,137	A	$ 31.6081		62,365			D
Common shares without par value				01/31/2014					M		5,715	A	$ 33.88		68,080			D
Common shares without par value				01/31/2014					M		1,546	A	$ 35.08		69,626			D
Common shares without par value				01/31/2014					S		2,598	D	$ 36.19		67,028			D
Common shares without par value				01/31/2014					S		5,608	D	$ 36.2		61,420			D
Common shares without par value				01/31/2014					S		1,192	D	$ 36.21		60,228			D
Common shares without par value															15,475 (1)			I	Profit Sharing Trust
Common shares without par value															500 (2)			I	By
																			daughter
Common shares without par value															500 (2)			I	By
																			daughter
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)			7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)			8. Price of Derivative Security (Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction (s) (Instr. 4)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date		Title	Amount or Number of Shares
Option (right to buy) (3)	$ 31.6081	01/31/2014		M			2,137	04/27/2013	02/19/2014		Common shares	2,137		$ 0		0		D
Option (right to buy) (3)	$ 33.88	01/31/2014		M			5,715	08/02/2013	02/19/2014		Common shares	5,715		$ 0		0		D
Option (right to buy) (3)	$ 35.08	01/31/2014		M			1,546	08/20/2013	02/19/2014		Common shares	1,546		$ 0		0		D

Explanation of Responses:

2/4/2014

Page 2 of 2

SEC FORM 4

1. Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2014.

2. The reporting person disclaims beneficial ownership of all securities held by his daughter.

3. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

mpt from Section 16 under Rule 16b-3.
John A. Berry, Attorney-in- Fact for Robert E. Funck ** Signature of Reporting Person
	02/04/2014
	Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

2/4/2014